![120px-Motor_neurons](https://can-acn.org/wp-content/uploads/2011/07/120px-Motor_neurons-e1313806407985-118x150.gif)
July 14, 2011 – Researchers at the Institut de recherches cliniques de Montréal (IRCM) are among the many scientists around the world trying to unearth our nervous system’s countless mysteries. A new piece of the puzzle was recently uncovered by Dr. Artur Kania, Director of the IRCM’s Neural Circuit Development research unit and Associate Professor at Université de Montréal’s Department of Medicine, and a postdoctoral fellow in his laboratory, Dr. Tzu-Jen Kao.
Scientists studying neural development aim to provide insight into the mechanisms that build our nervous system, which contains networks of specialized cells called neurons. Neurons send signals to one another and compute appropriate responses to sensory stimuli.
“For example, neural circuits enable our hands to move away from a burning ember or direct the precise movements of a surgeon’s fingers,” mentions Dr. Kania. “My laboratory focuses on spinal motor neurons that control muscles and are located in the spinal cord.”
In the developing nervous system, axon guidance is the process by which neurons send out axons (long extensions that form our nerves) in order to connect to their correct targets. Growing axons are, in turn, guided towards their targets by signals transmitted from molecules called “ligands,” which bind to special “receptors” on the surface of the axon.
“What is really surprising is that our nerves develop using relatively few ligands and receptors,” says Dr. Kania. “We still do not quite understand how, during the development of the nervous system, so few of these molecules manage to form the multitude of existing nerve connections with such accuracy.”
To answer this question, Drs. Kania and Kao have been studying the development of motor neuron axons growing into limb muscles. They noticed that in this motor system, the ligands (called ephrins) are present in the same neuron as receptors (called Ephs).
“We showed that ligands present in the neuron bind to their receptors and render them unresponsive to the other ligands in the environment,” says Dr. Kao. “Thus, an axon guidance ligand can alter the sensitivity of growing axons to environmental signals, which increases the diversity of axon guidance responses.”
The scientific breakthrough made by Drs. Kania and Kao will be published in today’s issue of Neuron, a scientific journal of the Cell Press group. “Our experiments shed light on poorly understood mechanisms of neuronal development” adds Dr. Kania. “Our breakthrough in the motor system offers the scientific community a new basis for explaining how the function of such few molecules can be modulated to produce a vast array of neuronal connections.”
Research carried out in Dr. Kania’s laboratory was funded by the Canadian Institutes of Health Research (CIHR), the Fonds de recherche en santé du Québec (FRSQ), and the EJLB Foundation. For more information on this discovery, please refer to the article summary published in Neuron.
About Artur Kania
Artur Kania obtained his PhD in human and molecular genetics from Baylor College of Medicine in Texas, USA. He is an Associate IRCM Research Professor and Director of the Neural Circuit Development research unit. Dr. Kania is also assistant professor in the Department of Medicine at the Université de Montréal, and associate member of the Department of Medicine (Division of Experimental Medicine), the Department of Biology, and the Department of Anatomy and Cell Biology at McGill University. In addition, he is a member of the Centre of Excellence in Neurosciences (CENUM) at the Université de Montréal. Dr. Kania is a Senior Research Scholar from the Fonds de la recherche en santé du Québec (FRSQ).
About the Institut de recherches cliniques de Montréal (IRCM)
Founded in 1967, the IRCM (www.ircm.qc.ca) is currently comprised of 35 research units in various fields, namely immunity and viral infections, cardiovascular and metabolic diseases, cancer, neurobiology and development, systems biology and medicinal chemistry. It also houses three specialized research clinics, seven core facilities and two research platforms with state-of-the-art equipment. The IRCM employs 425 people and is an independent institution affiliated with the Université de Montréal. The IRCM clinic is associated to the Centre hospitalier de l’Université de Montréal (CHUM). The IRCM also maintains a long-standing association with McGill University.
For more information and to schedule an interview with Dr. Kania, please contact:
Julie Langelier
Communications Officer (IRCM)
julie.langelier@ircm.qc.ca
514-987-5555
Lucette Thériault
Communications Director (IRCM)
lucette.theriault@ircm.qc.ca
514-987-5535